Network bioinformatics analysis provides insight into drug repurposing for COVID-19
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly ent...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2021-06-01
|
| Серія: | Medicine in Drug Discovery |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2590098621000117 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|